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1502Objective: The aim of this study was to evaluate the effect of center volume on the incidence of postoperative
complications and their impact on survival after lung transplantation (LTx).
Methods: United Network for Organ Sharing data were used to identify adult patients undergoing LTx between
1999 and 2009. Center volumewas modeled as both a continuous and a categorical variable. Postoperative com-
plications included infection, rejection, stroke, reoperation, and renal failure requiring dialysis. Multivariable
Cox regression and Kaplan-Meier analyses were conducted after stratification on the basis of center volume
and type of complication.
Results: A total of 12,565 LTx recipients were included in the study. Overall rates of postoperative complica-
tions were 5.4% for renal failure requiring dialysis, 1.9% for stroke, 19.9% for reoperation, 42.8% for infec-
tion, and 10.0% for rejection. High volume centers did not have significantly reduced rates of postoperative
complications. Risk-adjusted multivariable Cox analysis demonstrated that in patients with a complication,
low volume center was a significant risk factor for increased 90-day, 1-year, and 5-year mortality. Kaplan-
Meier analyses similarly demonstrated reduced posttransplant survival in lower volume centers, a finding
that persisted after stratification based on individual complication type except for stroke.
Conclusions: Although high volume centers do not have significantly lower incidences of individual postoper-
ative complications after LTx, they are best able to minimize the adverse effects of these complications on short-
and long-term survival. These data suggest that identifying and implementing the institutional practices that lead
to better management of postoperative complications after LTx in high volume centers may be prudent to im-
proving outcomes in lower volume hospitals. (J Thorac Cardiovasc Surg 2012;144:1502-9)Prior studies have demonstrated that higher center volume is
associated with improved survival after lung transplantation
(LTx).1,2 However, the mechanisms by which higher volume
leads to reduced mortality remain unknown. Some of these
mechanisms may be related to postoperative complications.
Moreover, centers that are able to reduce the rates of
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The Journal of Thoracic and Cardiovascular Suroccur should theoretically have improved outcomes. It is
unclear whether center volume affects these factors.
Therefore, in this study, we analyzed the effect of center
volume on the incidence of postoperative complications
and their impact on short- and long-term survival after LTx.PATIENTS AND METHODS
Data Source
Data from the United Network for Organ Sharing (UNOS) were ob-
tained for the purposes of this analysis. The UNOS registry is a publically
available deidentified data set that contains patient-level data on all trans-
plantations performed in the United States. The Johns Hopkins University
School of Medicine Institutional Review Board approved this study.
Inclusion and Exclusion Criteria
We included all adult patients over the age of 17 years who underwent
LTx between January 1, 1999, and December 31, 2009. Pediatric patients
were excluded from the study. Patients undergoing redo LTx, heart–lung
transplantation, or other types of multivisceral transplantation were also
excluded.
Center Volume and Postoperative Complications
Patients were initially distributed into equal-sized tertiles on the basis of
center LTx volume. These tertiles were used to define low, intermediate,
and high volume centers. The rates of postoperative complications were
then compared among these cohorts. Postoperative complications were de-
fined as occurring before discharge after LTx. The individual complications
that were included in our analysis were renal failure requiring dialysis,gery c December 2012
Abbreviations and Acronyms
CI ¼ confidence interval
LTx ¼ lung transplantation
OR ¼ odds ratio
UNOS ¼ United Network for Organ Sharing
Kilic et al Cardiothoracic Transplantationstroke, all-cause reoperation, infection, and rejection. Risk-adjusted
analysis was also performed incorporating univariate predictors (P<.2)
of these complications to evaluate the independent effect of center volume
both as a continuous variable and as a categorical variable on these adverse
event rates.
The availability of complications data within the UNOS database was
different for different complication types. Moreover, renal failure requiring
dialysis and stroke were available uniformly throughout our study period
from 1999 to 2009. Only 2.1% and 2.3% of data were missing for these
complications, respectively. Reoperation and infection were only available
from 1999 to 2006, with no coding from 2007 onward. In the years that
these complications were available, data were missing in only 3.1% and
3.2%, respectively. Finally, rejection occurring before discharge, although
coded throughout the study period, was poorly coded before 2004. From
2004 to 2009, only 4.2% of data were missing. The data presented herein
represent data for these specific years for each complication type.
After examining the rates of postoperative complications, we evaluated
the impact of these complications on short- and long-term survival, strati-
fied by center volume. Moreover, end points included 90-day, 1-year, and
5-year all-cause mortality, as well as 1-year mortality excluding 90-day
deaths and 5-year mortality excluding 1-year deaths. Multivariable Cox re-
gression analyses incorporating recipient, donor, and transplant variables
associated with these end points in univariate analysis (P<.2 in exploratory
analysis) were conducted, as were Kaplan-Meier analyses. Statistical anal-
yses were performed using STATA software version 11 (StataCorp LP, Col-
lege Station, Tex).T
XRESULTS
Baseline Characteristics
A total of 12,565 adult patients underwent LTx at 77
transplant centers between 1999 and 2009 and met eligibil-
ity criteria for our study. The average annual center volume
for the overall cohort was 31.1  17.9 LTx per year. After
patients were divided into equal-sized tertiles, this
corresponded to the following thresholds: low (<21.8
LTx per year), intermediate (21.8-34.2 LTx per year), and
high (>34.2 LTx per year) volume.
When the annual volume of LTx at each individual
center across the study period were examined, there were
9 (11.7%) programs that ‘‘came online,’’ meaning they
did not initially perform any transplants in the earlier part
of the study period and then began performing LTx in later
years. Each of these programs was categorized as low vol-
ume based on their aggregate volume, and when examined
on an annual basis, all but 2 (2.6%) had indeed been low
volume for each of the years in the study period. These other
2 programs were initially low volume but had consistently
grown over the study period and were in fact high volume
by the end of the study interval. Excluding these centers
produced the same results; therefore, for simplicity, weThe Journal of Thoracic and Carincluded these 2 centers in the low volume cohort based
on their aggregate volume. Overall, the standard deviation
within each individual center for annual LTx volume was
6.2 transplants.
There were several differences when comparing key base-
line recipient characteristics between center volume cohorts
(Table 1). High volume centers tended to transplant older pa-
tients, more male patients, and more white patients. Serum
creatinine was statistically higher in low volume centers.
There were also differences in etiology of lung disease, such
that high volume centers had a higher proportion of idiopathic
pulmonary fibrosis as compared with low volume centers. Fi-
nally, there was a higher acuity of recipients at high volume
centers, inasmuch as the proportion of patients bridged with
mechanical ventilation or extracorporeal membrane oxygen-
ation was significantly higher at these institutions.
Therewere key differences in donor characteristics aswell
(Table 1). High volume centers used older donors and also
had a higher frequency of female donors.Ahigher proportion
of donors at high volume centers were white, and fewer had
a traumatic mechanism of death. With respect to transplant
variables, high volume centers used bilateral LTx more fre-
quently than low or intermediate volume centers (Table 1).
High volume centers also had longer ischemic times, which
was in part a reflection of procuring organs from donors lo-
cated at greater distances from the transplant center.
Rates of Postoperative Complications
The overall rates of complications for the entire study co-
hort were as follows: 5.4% for renal failure requiring dial-
ysis, 1.9% for stroke, 19.9% for reoperation, 42.8% for
infection, and 10.0% for rejection. In examining temporal
trends, the rates of renal failure, stroke, and reoperation
did not significantly change over time. Conversely, the
rate of infection significantly increased from 40.9% in
1999 to 46.9% in 2006 (P value for trend ¼ .008). The
rate of rejection significantly declined from 13.2% in
2004 to 9.0% in 2009 (P value for trend ¼ .002).
There were significant differences in the rates of
postoperative complications by center volume cohort, ex-
cept for stroke, which was comparable between groups
(Figure 1). More specifically, intermediate and high volume
centers had a comparable rate of renal failure requiring di-
alysis (4.9% and 4.7%, respectively), which was signifi-
cantly lower than the rate of 6.5% observed in low
volume centers (P<.001). For the remaining 3 complica-
tions (reoperation, infection, and rejection), intermediate
volume centers consistently had the lowest rate, which
was significantly less than the rates observed in low and
high volume centers (each P<.05) (Figure 1).
After risk adjustment, center volume displayed compara-
ble trends to unadjusted analysis when modeled as
a categorical variable. Moreover, low volume centers had
significantly higher odds of postoperative dialysis (oddsdiovascular Surgery c Volume 144, Number 6 1503
TABLE 1. Baseline characteristics stratified by center volume
Variable Low volume (n ¼ 4460) Intermediate volume (n ¼ 4227) High volume (n ¼ 3878) P value*
Recipient
Age (y) 51.4  13.0 52.3  12.4 53.1  12.5 <.001
Female gender 2086 (46.8%) 1939 (45.9%) 1688 (43.5%) .01
White race 3723/4440 (83.9%) 3670/4218 (87.0%) 3484/3871 (90.0%) <.001
Diagnosis .03
COPD 1663 (37.3%) 1520 (36.0%) 1355 (34.9%)
IPF 1269 (28.5%) 1283 (30.4%) 1190 (30.7%)
CF 649 (14.6%) 574 (13.6%) 504 (13.0%)
Other 879 (19.7%) 850 (20.1%) 829 (21.4%)
Bridging with ECMO 18 (0.4%) 20 (0.5%) 38 (1.0%) .001
Mechanical ventilation 120 (2.7%) 160 (3.8%) 166 (4.3%) <.001
Serum creatinine (mg/dL) 0.91  0.60 0.88  0.44 0.88  0.56 .01
Donor
Age (y) 32.4  13.8 32.4  13.8 34.3  14.7 <.001
Female gender 1707 (38.3%) 1670 (39.5%) 1623 (41.9%) .004
White race 2881/4441 (64.9%) 2824/4212 (67.1%) 2789/3863 (72.2%) <.001
Trauma as mechanism of death 2297/4437 (51.8%) 2155/4186 (51.5%) 1765/3869 (45.6%) <.001
Transplant
Bilateral LTx 2254 (50.5%) 2065 (48.9%) 2728 (70.4%) <.001
Median distance between donor
hospital and transplant center (mile)
68.9 (IQR 7.4-210.0) 97.8 (IQR 15.5-269.1) 196.2 (IQR 49.5-359.3) <.001
Ischemic time (h) 4.5  1.6 4.8  1.7 5.4  1.7 <.001
Continuous data were presented as mean standard deviation, except for distance between donor hospital and transplant center, which was presented as median with interquartile
range. Frequency data were presented as number (percentage). All percentages for frequency data were based on all patients within the cohort unless otherwise indicated. COPD,
Chronic obstructive pulmonary disease; IPF, interstitial pulmonary fibrosis; CF, cystic fibrosis; ECMO, extracorporeal membrane oxygenation; LTx, lung transplantation; IQR,
interquartile ratio. *P value based on c2 for frequency data and analysis of variance for continuous data. P value for median distance based on Kruskal-Wallis nonparametric test.
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Xratio (OR), 1.79; P < .001), reoperation (OR, 1.28;
P ¼ .007), and infection (OR, 1.27; P ¼ .001), and signifi-
cantly lower odds of rejection (OR, 0.79; P ¼ .02) as com-
pared with high volume centers. The risk-adjusted odds of
stroke were comparable in low (OR, 1.24; P ¼ .25) versus
high volume centers. When compared with high volume
centers, intermediate volume centers had comparable risk-
adjusted odds of stroke (OR, 1.22, P¼ .28) and reoperation
(OR, 0.90; P ¼ .26), higher risk-adjusted odds of renal
failure (OR, 1.31; P ¼ .04), and significantly lower risk-
adjusted odds of infection (OR, 0.78; P ¼ .001) and rejec-
tion (OR, 0.55; P<.001).FIGURE 1. Rates of postoperative complications by center volume.
1504 The Journal of Thoracic and Cardiovascular SurWhen modeled as a continuous variable, decreasing cen-
ter volume was found to be associated with a significantly
increased risk-adjusted likelihood of renal failure (OR,
1.01; P< .001) and infection (OR, 1.01; P< .001). The
risk-adjusted odds of stroke, reoperation, and rejection
were not significantly affected by center volume as a contin-
uous variable (each P>.05).Impact of Complications on Survival
Each individual complication significantly increased
the likelihood of risk-adjusted posttransplant mortality
(each P  .001) when examined independent of each other.
The hazard ratio for death ranged from 1.26 in those with
rejection to 4.18 in those with renal failure requiring dialy-
sis after LTx. Kaplan-Meier analysis excluding patients
with multiple complications demonstrated that 5-year sur-
vivals ranged from 61.0% (95% confidence interval [CI],
58.1%-63.7%) in those with no complications to 15.4%
(95% CI, 1.2%-45.3%) in those with postoperative renal
failure requiring dialysis (log–rank P value < .001).
Shorter-term survival displayed the same trends, with 90-
day and 1-year survivals ranging from 97.2% (95% CI,
96.2%-97.9%) and 91.1% (95% CI, 89.5%-92.5%) in those
with no complications to 53.9% (95% CI, 24.8%-76.0%)
and 46.2% (95% CI, 19.2%-69.6%) in patients requiring di-
alysis, respectively.gery c December 2012
Kilic et al Cardiothoracic TransplantationSimilarly, Kaplan-Meier analysis confirmed that an in-
creasing number of complications was associated with sig-
nificantly decreasing short- and long-term survivals
(Figure 2). Moreover, 90-day survival ranged from 97.2%
(95% CI, 96.2%-97.9%) in patients with no complications
to 67.3% (95% CI, 60.5%-73.2%) in patients with at least
3 complications (P<.001). Survival at 1 year ranged from
91.1% (95% CI, 89.5%-92.5%) to 45.3% (95% CI, 38.5%-
51.9%) and at 5 years from 61.0% (95% CI, 58.1%-
63.7%) to 27.6% (95% CI, 21.6%-33.8%) in patients with
no complications versus thosewith 3 ormore complications,
respectively (each P<.001). In risk-adjusted analysis incor-
porating all complications, renal failure (OR, 3.84; P<
.001), stroke (OR, 1.66; P ¼ .008), and reoperation (OR,
1.71; P<.001) were all associated with an independent in-
crease in odds of post-LTxmortality, whereas the adverse ef-
fect of early rejection (OR, 1.09;P¼ .36) and infection (OR,
1.01; P ¼ .84) no longer persisted.Impact of Center Volume on Survival in Patients
With Complications
In risk-adjusted multivariable Cox regression models lim-
ited to patients with a postoperative complication, center vol-
ume was found to significantly affect post-LTx mortality
(Table 2). More specifically, when modeled both as
a continuous and categorical variable, decreasing center vol-
ume correlated with a significant increase in 90-day, 1-year,
and 5-year mortality risk. The strongest effect was at the
90-daymark,where recipients undergoingLTxwithapostop-
erative complication at a low volume center were at a 52%
increased risk ofmortality comparedwith patients experienc-
ing a complication at a high volume center (P<.001). Low
volume centers similarly exhibited a 46% and 32% in-
creased risk of mortality relative to high volume centers at
1 year and 5 years in these cases with complications (each
P<.001). To ensure that the effects of center volume on over-
all 1- and 5-year mortality were not accounted for by the ef-
fects on earlier mortality, we conducted a time-segmented
analysis. Moreover, in this analysis, center volume both asFIGURE 2. Kaplan-Meier survival stratified by number of complications.
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Xa continuous and categorical variable was found to affect
1-year mortality excluding 90-day mortalities, as well as
5-year mortality excluding 1-year mortalities (Table 3).
Kaplan-Meier analysis confirmed these findings. More-
over, high volume centers had improved 90-day (88.8%
vs 84.2%; P<.001), 1-year (77.9% vs 71.8%; P<.001),
and 5-year (49.1% vs 38.9%; P<.001) survivals as com-
pared with low volume centers in patients with a postopera-
tive complication (Figure 3, A). Except for stroke, the
correlation between center volume and posttransplant sur-
vival remained significant when performing separate analy-
ses for each individual complication type (each log–rank
P value< .05) (Figure 3, B-F).
DISCUSSION
Procedural volume has been shown to correlate with oper-
ative outcomes in numerous studies. In their landmark study,
Birkmeyer and colleagues3 surveyed the Nationwide Inpa-
tient Sample and Medicare claims database to examine the
impact of hospital volume on operative mortality in 6 differ-
ent cardiovascular procedures and 8major cancer resections.3
They found in their analysis of over 2.5 million procedures
that higher volume hospitals had reduced risk-adjusted
operative mortality for all procedures. This study along
with others helped form the foundation for the Leapfrog rec-
ommendations and other evidence-based hospital referrals.4,5
In the realm of LTx, several studies have shown similar
results. Weiss and coworkers1 examined over 10,000 pri-
mary LTx cases from the UNOS database and found that re-
cipients at low volume centers were at increased risk of
short-term mortality. Scarborough and coworkers2 also
demonstrated the significant association between center
volume and 1-year mortality in LTx and, in addition, found
that the volume–outcomes relationship has become even
more pronounced over time.
A central question that has arisen from these studies iswhat
drives this relationship between procedural volume and mor-
tality. One theoretical contributor may be related to postoper-
ative complications. Moreover, it can be postulated that high
volume centers achieve improved survival by reducing the
rates of postoperative complications, recognizing their occur-
rence earlier, and/or better managing them once they occur.
Therefore, in this study, our aimwas to evaluate the effect
of center volume on the incidence of complications and
their impact on survival after LTx. The principal finding
in our analysis of over 12,000 LTx cases was that although
high volume centers do not have significantly lower inci-
dences of postoperative complications, they are best able
to mitigate the adverse effects of these complications on
short- and long-term survival.
Prior Studies
Several prior studies have similarly examined the effect
of center volume on rates of complications and their impactdiovascular Surgery c Volume 144, Number 6 1505
TABLE 2. Risk-adjusted impact of center volume on 90-day, 1-year, and 5-year post-LTx mortality in patients with a postoperative complication
Center volume
Ninety-day*
HR (95% CI)
One-yeary
HR (95% CI)
Five-yearz
HR (95% CI)
Decreasing center volume (continuous) 1.01 (1.01-1.02)x 1.01 (1.00-1.01)x 1.01 (1.00-1.01)x
Center volume (categorical)
High Reference Reference Reference
Intermediate 1.30 (1.30-1.64)x 1.18 (0.99-1.41) 1.03 (0.90-1.18)
Low 1.52 (1.22-1.90)x 1.46 (1.24-1.72)x 1.32 (1.17-1.50)x
HR, Hazard ratio; CI, confidence interval. *Risk-adjusted for univariate predictors (P<.2) of 90-day mortality: age, weight, serum creatinine, serum bilirubin, body mass index,
race, gender, mechanical ventilation, intensive care unit before transplant, etiology of lung disease, dialysis while on wait list, red blood cell transfusion while on wait list, donor
weight, donor cytomegalovirus status, donor race, donor/recipient body mass index ratio, recipient–donor race-matching, and bridge to transplant with extracorporeal membrane
oxygenation. yRisk-adjusted for univariate predictors (P<.2) of 1-year mortality: age, weight, single versus bilateral lung transplantation, serum creatinine, serum bilirubin, body
mass index, race, gender, mechanical ventilation, intensive care unit before transplant, etiology of lung disease, dialysis while on wait list, red blood cell transfusion while on wait
list, donor weight, donor cytomegalovirus status, donor diabetes, donor terminal creatinine, donor race, donor/recipient bodymass index ratio, recipient/donor race-matching, and
bridge to transplant with extracorporeal membrane oxygenation. zRisk-adjusted for univariate predictors (P<.2) of 5-year mortality: age, weight, single versus bilateral lung
transplantation, serum creatinine, serum bilirubin, days on wait list, body mass index, gender, mechanical ventilation, intensive care unit before transplant, etiology of lung dis-
ease, recipient cytomegalovirus status, dialysis while on wait list, red blood cell transfusion while on wait list, donor age, donor cytomegalovirus status, donor cigarette use, donor
diabetes, donor race, donor/recipient body mass index ratio, ischemic time, and bridge to transplant with extracorporeal membrane oxygenation. xP<.05.
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Xon surgical mortality. A study of over 35,000 pediatric heart
surgery patients from the Society of Thoracic Surgeons
Congenital Heart Surgery Database demonstrated no asso-
ciation between center volume and rates of complications,
but it did show a significant association between center vol-
ume and mortality from complications, similar to our anal-
ysis.6 Another study by Ghaferi, Birkmeyer, and Dimick7
used Medicare data to examine this issue in patients under-
going gastrectomy, pancreatectomy, and esophagectomy.
They found that differences in mortality between low and
high volume centers were not attributable to significant dif-
ferences in complication rates but rather the ability of
hospitals to ‘‘rescue’’ patients from these complications,
or in other words, prevent mortality once the complication
occurred.
Another study of 1864 patients undergoing gastrectomy
for gastric cancer at 214 hospitals located in Texas similarly
demonstrated that although adverse event rates were com-
parable between low and high volume hospitals, mortality
rates in patients with these events were significantly in-
creased at low volume centers.8 These studies support theTABLE 3. Risk-adjusted impact of center volume on 1-year and 5-year po
patients with a postoperative complication
Center volume
One year excluding 90-
HR (95%
Decreasing center volume (continuous) 1.01 (1.00-1
Center volume (categorical)
High Referenc
Intermediate 1.12 (0.94-1
Low 1.50 (1.26-1
HR, Hazard ratio; CI, confidence interval. *Risk-adjusted for univariate predictors (P<.
transplantation, serum creatinine, year of transplant, gender, mechanical ventilation, diabe
malignancy, cytomegalovirus status, red blood cell transfusion while on wait list, donor age
diabetes, donor terminal creatinine, donor race, recipient–donor gender matching, recipien
adjusted for univariate predictors (P<.2) of 5-year mortality excluding 1-year mortalities:
days on wait list, diabetes mellitus, intensive care unit before transplant, etiology of lung
diabetes, donor terminal creatinine, donor race, recipient–donor race matching, and ische
1506 The Journal of Thoracic and Cardiovascular Surnotion that the ability to recognize and effectively manage
major postoperative complications may be a mechanism
by which higher volume institutions achieve improved
outcomes.
Potential Reasons for Our Findings
The reasons why higher volume centers have improved
survival after LTx in patients with a postoperative complica-
tion despite similar rates of occurrence are difficult to ascer-
tain from variables available in the UNOS dataset. One
potential reason may be related to nursing and intensive
care unit staffing. In the aforementioned study of gastrecto-
mies by Smith and colleagues,8 for instance, fewer critical
care beds and higher licensed vocational nurse/patient
ratios were associated with worse outcomes. The authors
postulated that critical care beds may be a surrogate for
the availability of expertise within the hospital, such as in-
terventional radiology, as well as the overall experience of
the center. Inasmuch as vocational nurses practice under
the supervision of registered nurses, the authors also sug-
gested that having a larger proportion of the nursing staffst-LTx mortality excluding 90-day and 1-year deaths, respectively, in
day mortalities*
CI)
Five years excluding 1-year mortalitiesy
HR (95% CI)
.01)z 1.01 (1.00-1.01)z
e Reference
.34) 0.93 (0.83-1.04)
.78)z 1.23 (1.10-1.38)z
2) of 1-year mortality excluding 90-day mortalities: age, single versus bilateral lung
tes mellitus, intensive care unit before transplant, etiology of lung disease, previous
, donor weight, donor height, donor cytomegalovirus status, donor cigarette use, donor
t–donor race matching, and recipient–donor cytomegalovirus status matching. yRisk-
age, single versus bilateral lung transplantation, serum creatinine, year of transplant,
disease, dialysis while on wait list, donor age, donor cytomegalovirus status, donor
mic time. zP<.05.
gery c December 2012
FIGURE 3. Kaplan-Meier survival curves stratified by center volume for patients with any complication (A), renal failure requiring dialysis (B), stroke
(C), reoperation (D), infection (E), and rejection (F).
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Xbe comprised of vocational nurses may lead to worse out-
comes inasmuch as more experienced staff may be better
able to identify complications early in their course.
Other studies have confirmed this latter concept as well.
Aiken and associates9 demonstrated lower surgical mortal-
ity and higher rescue from complication rates in hospitals
with higher registered nurse/patient ratios. Another study
by the same group found that having nurses with higher ed-
ucation levels similarly resulted in reduced mortality and
improved rescue from complications.10
Another factor that may contribute to the findings in our
study is the use of standardized clinical pathways. These
pathways are more likely to be present in higher volume
centers and may be important in the early recognition and
effective clinical management of major complications.
Although the impact of these pathways on rescue fromThe Journal of Thoracic and Carcomplications or in LTx in general has not beenwell studied,
prior studies have demonstrated their association with im-
proved outcomes and reduced costs in other procedures.11-13
Limitations
As mentioned previously, the major limitation to our
study is the absence of certain institutional variables in
the UNOS database that are important to better understand-
ing the relationship between center volume and the ability
to reduce mortality from complications after LTx. These
variables include nurse/patient ratios, staffing and resources
in the intensive care unit, house staff coverage, standardized
clinical pathways, and the availability and expertise of sub-
specialty services. Another limitation is that complications
are simply coded as being present or absent in the UNOS
registry. The degree or severity of these complications isdiovascular Surgery c Volume 144, Number 6 1507
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Xnot provided, although this would certainly be expected to
affect mortality rates. Also, the timing of the complication
in relation to the LTx is also not available in the dataset;
therefore, time zero could not be defined as the time of
the complication but rather had to be defined as the date
of the LTx.
A limitation of our statistical analysis is that center
volume is a dynamic variable that changes on an annual
basis. In other words, a center that may be low volume in
earlier years may become higher volume over time, or
vice versa. We chose to use aggregate volume to account
for these year-to-year changes. Despite this limitation, we
found that the average standard deviation for annual volume
within each individual center was only 6.2 LTx; further-
more, only 2 (2.6%) programs that had come online during
the study period would have been reclassified as their vol-
ume changed significantly over the study interval.
Additionally, aside from renal failure and stroke, compli-
cations were not uniformly coded throughout the study pe-
riod for each complication type. However, in the years that
the complications were available, the coding was relatively
complete for the majority of patients. Furthermore, inas-
much as there is variable length of hospital stay after LTx,
the ‘‘exposure’’ to developing early complications is also
variable between patients and between centers. We also
did not include quality of life data, although this is certainly
an important outcome in LTx and likely correlates with
rates of complications. A final limitation was that we could
not determinewhether patient mortality was related to a spe-
cific complication or not, and if so, to what degree. Al-
though coding is available for the cause of death in
patients in the UNOS dataset, the sequence of clinical
events leading to a patient’s death can be complex and the
etiology of death is often multifactorial. Therefore, a simple
code for 1 cause of death is often not convincing of whether
the death was in actuality related in any way to a specific
complication.CONCLUSIONS
In this review of over 12,000 patients with primary LTx,
we found that higher volume centers did not have signifi-
cantly lower rates of postoperative complications but were
best able to mitigate the adverse effects of these complica-
tions on both short- and long-term survival. These data
suggest that identifying and implementing the institutional
practices that lead to better management of postoperative
complications after LTx in high volume centers may be
prudent to improving outcomes in lower volume hospitals.References
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DrMatthewBacchetta (New York, NY). I thank the Association
for the opportunity to comment on this excellent paper and I thank
the authors and Dr Kilic for providing me a copy well in advance.
The theme of superiority of high volume centers versus low
volume centers with respect to quality of outcome is certainly
not new, yet it continues to expand over a range of operative pro-
cedures from the abdomen to the chest. The Johns Hopkins group
reported a similar paper in 2009 at the meeting of The Society of
Thoracic Surgeons about the value of high volume centers for im-
proved outcome. We have another paper here that suggests similar
conclusions, yet there are clearly some major differences in the
focus, analysis, observations, and conclusions. In essence, your
analysis found that postoperative complication rates were approx-
imately the same across all groups, suggesting that we have stan-
dardized our preoperative assessment of patients and standardized
our immunosuppression and surgical techniques, with only slight
institutional variability, which has led to uniform complication
rates across your groups, yet the short-term and long-term impact
of these complications was significantly influenced by center
volume. Your study suggests that anybody can build a car but
only a few know how to fix it when it breaks. Begging the question
is, are high volume centers better at fixing cars than low volume
centers simply because they have more service centers? They
have more staff, transplant pulmonologists, and so on. With that
in mind, I have a few technical questions and a few more policy-
oriented questions.gery c December 2012
Kilic et al Cardiothoracic Transplantation
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XThe paper from 2009 used 20 cases per year as the inflection
point for low and high volume. In your analysis you have come
up with 21.8. You chose to use tertiles as opposed to the quartiles
that were used in 2009. It seems a bit arbitrary. I hope that you will
delve into that a little bit. Is there a meaningful difference between
a center that is doing 20 transplants per year and one that’s doing
22? Why not analyze the outcomes of centers doing 5 or 10 or less
per year as ultra–low volume centers? Do you have any data that
might hint at that outcome of these ultra–low volume centers?
Is the difference in outcome borne from a deficit in staffing at
low volume centers, which can easily become overwhelmed
when a major postoperative complication occurs—anastomotic
leaks, primary graft dysfunction, renal failure, and so forth? At
our institution we have many transplant pulmonologists who are
dedicated to this, and it makes it easier to manage these types of
complications. Is it really simply a matter of staffing? There are
some low volume centers that have very good outcomes, as good
as high volume centers. How does your study address the issue
of what makes for a center of excellence in lung transplantation?
Can we use your study to implement changes in lung transplan-
tation that will improve national outcomes? Given that 35% of all
the lung transplants during your study period were done by low
volume centers, that is a big number and has huge policy implica-
tions and staffing implications. The hope of a lot of epidemiologic
studies is to provide some guidance for policy recommendations.
Should we conclude that lung transplantation should be restricted
to centers that do 22 transplants or more, or does this provide the
ground for regionalization?
Dr Kilic. Thank you, Dr Bacchetta, for those comments and
questions.
We modeled center volume both as a continuous variable,
where it was found to have significant impact at each of the
time points, as well as a categorical variable. Defining it according
to a categorical variable really was done so that we could plot
Kaplan-Meier analyses; otherwise, there is really no way to do
it when you have it as a continuous variable, and we thought
that the best way to do it would be to divide the centers into
equal-sized patient tertiles. We did not show the data here, but
if you plot annual center volume as a continuous variable and
look at mortality on the y-axis, the best discriminatory threshold
for survival is around 20, and that is with both uncomplicated
and complicated cases. I do think that is the optimal volume
threshold. Having said that, though, and this ties in with your
question about regionalization, although taken as a whole, the
high volume centers have improved outcomes, there is a cohort
of low volume centers that consistently have good outcomes every
year. I do not think this information is meant to penalize all the
low volume centers, but I think it does indicate that we need to
identify what the specific practices are in the high volume centers
so that we can translate them into the poorly performing low vol-
ume centers. In terms of what those practices may be specifically
relating to complications, if we talk about identifying complica-
tions early, I think it does have to do with staffing. Studies have
shown that nurse/patient ratios, for instance, or qualifications of
nurses have an important impact on identifying complications
and rescue from complication rates. In terms of managing the
complications once they are identified, I think availability ofThe Journal of Thoracic and Carconsult services, individual surgeon experience, and other cen-
ter-level factors would have an important impact. Perhaps another
important step would be to have UNOS and some of these other
registries start to collect institutional variables beyond volume
so that we can at least start to study them and see which ones
are important factors in contributing to outcomes.
Dr Thomas K. Waddell (Toronto, Ontario, Canada). I want to
ask about the statistics of the hazard ratio that you gave for later
time periods, 1 and 5 years. I understand the concept of failure
to rescue; somebody has a bad complication and you have to see
a lot of them in order to rescue them and pull them out of the in-
tensive care unit. I am unclear about the impact of early complica-
tions on 5-year mortality as a failure to rescue model. I do not quite
understand that. Did you actually model hazard function as 2 func-
tions, an early acute risk and a slower plateau phase kind of
hazard? If you did find that the plateau phase hazard was in fact
affected by center volume, what do you think is the medical equiv-
alent of failure to rescue in that situation?
Dr Kilic. Thank you for that question. We did actually look at
conditional survival as well. When you incorporate conditional
survival to 90 days, there is still an important center volume effect
beyond that to the 1-year and 5-year mark. I do agree that at 1 year
and 5 years, it is hard to delineate exactly how much of that is re-
lated to the complication versus other factors that may develop in
the longer term. Our analysis does not show the mortalities related
to these complications. It simply shows that in patients who have
a complication, the survival is better when they are at a higher
volume center, and we can presume that it may be related to that
complication. Renal failure, for instance, causes a dramatic de-
cline in survival. It is the worst of all the complications. We can
presume that it is due to that. However, again, this study was de-
signed for associative rather than causal relationships.
Dr Stephan Schueler (Newcastle upon Tyne, United Kingdom).
I come from a high volume lung transplant center. We do about 60
a year. The striking thing in your survival curves was actually the
fact that the 30-day drop in survival was identical among all the
centers. You would expect that this early attrition rate would be
much less in high volume centers, that is, the experienced centers,
because of their better judgment. Based on early or bad experience,
they should have better judgment in terms of picking the better
donor and managing the patients better. My second question is,
would your chest physicians now refer patients to high volume
centers according to your data?
Dr Kilic. To answer the first question, the effect was actually
the strongest in the short term. If you look at the hazard ratios in
the risk-adjusted analysis, the hazard ratio is actually the highest
at the 90-day mark and then weans down from there into the
1-year and 5-year marks. The effect is exactly what you are saying.
It is actually the greatest in the short term and then reduces in the
longer term.
To answer your second question, again, I do not think this infor-
mation is meant to say that we should regionalize all lung trans-
plants to high volume centers, inasmuch as some low volume
centers perform well. I think it just says that we need to do more
research to identify exactly why these volume-outcome relation-
ships exist and what we can do to implement those practices in
poorly performing low volume centers.diovascular Surgery c Volume 144, Number 6 1509
